Previous study reported that the effector function of tumor-infiltrating CD8+ T cells were impaired in ccRCC leading to the cell progression to exhaustion stage, which might account for tumor resistance to PD-1 blockade (4). The gene discussed is CD8A; the disease is neoplasm.